Live feed
Filing
SC 13G
SC 13G0000902664-21-000010·ADAGE CAPITAL PARTNERS GP, L.L.C.
Schedule 13G ownership disclosure
Tokai Pharmaceuticals Inc
Security class unavailable · CUSIP: 67011N204
Event date: 2020-12-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 892,555
- Percent of class
- 5.8900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-21-000010
- Form type
- SC 13G
- Filer
- ADAGE CAPITAL PARTNERS GP, L.L.C.
- CIK
- CIK 1165408
- Filed
- Jan 04, 2021
- Reporting period
- Dec 22, 2020
- Description
- Schedule 13G beneficial ownership